Kaisa Salmenkivi

4.2k total citations
83 papers, 3.2k citations indexed

About

Kaisa Salmenkivi is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research. According to data from OpenAlex, Kaisa Salmenkivi has authored 83 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Pulmonary and Respiratory Medicine, 25 papers in Molecular Biology and 25 papers in Cancer Research. Recurrent topics in Kaisa Salmenkivi's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (16 papers), Adrenal and Paraganglionic Tumors (12 papers) and Occupational and environmental lung diseases (11 papers). Kaisa Salmenkivi is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (16 papers), Adrenal and Paraganglionic Tumors (12 papers) and Occupational and environmental lung diseases (11 papers). Kaisa Salmenkivi collaborates with scholars based in Finland, United States and Germany. Kaisa Salmenkivi's co-authors include Vuokko L. Kinnula, Marjukka Myllärniemi, Johanna Arola, Päivi Heikkilä, Sakari Knuutila, Markku Kupari, Jukka Lehtonen, Riina Kandolin, Pamela Lindholm and Sisko Anttila and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, American Journal of Respiratory and Critical Care Medicine and Diabetes.

In The Last Decade

Kaisa Salmenkivi

83 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kaisa Salmenkivi Finland 33 1.2k 1.1k 983 638 416 83 3.2k
Jean-Michel Vignaud France 32 909 0.7× 935 0.8× 561 0.6× 526 0.8× 828 2.0× 87 2.9k
Aurélie Cazes France 32 1.6k 1.3× 957 0.9× 727 0.7× 564 0.9× 1.5k 3.7× 108 3.8k
Stephen M. Bonsib United States 32 1.7k 1.4× 1.4k 1.3× 553 0.6× 606 0.9× 355 0.9× 91 3.4k
Chin‐Chen Pan Taiwan 33 997 0.8× 951 0.9× 422 0.4× 848 1.3× 595 1.4× 100 2.8k
Shogo Katsuda Japan 25 518 0.4× 780 0.7× 415 0.4× 594 0.9× 488 1.2× 91 2.8k
Maria A. Pantaleo Italy 33 1.8k 1.4× 914 0.8× 633 0.6× 930 1.5× 1.0k 2.4× 217 4.0k
Robert Stöhr Germany 26 438 0.4× 1.2k 1.1× 789 0.8× 602 0.9× 538 1.3× 97 2.7k
Claudio Di Cristofano Italy 30 461 0.4× 778 0.7× 251 0.3× 480 0.8× 275 0.7× 98 2.1k
Seiichi Tamai Japan 28 662 0.5× 840 0.8× 353 0.4× 533 0.8× 720 1.7× 118 2.7k
Yoshiaki Inayama Japan 35 1.5k 1.2× 1.2k 1.1× 547 0.6× 1.0k 1.6× 1.2k 2.8× 194 3.9k

Countries citing papers authored by Kaisa Salmenkivi

Since Specialization
Citations

This map shows the geographic impact of Kaisa Salmenkivi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kaisa Salmenkivi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kaisa Salmenkivi more than expected).

Fields of papers citing papers by Kaisa Salmenkivi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kaisa Salmenkivi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kaisa Salmenkivi. The network helps show where Kaisa Salmenkivi may publish in the future.

Co-authorship network of co-authors of Kaisa Salmenkivi

This figure shows the co-authorship network connecting the top 25 collaborators of Kaisa Salmenkivi. A scholar is included among the top collaborators of Kaisa Salmenkivi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kaisa Salmenkivi. Kaisa Salmenkivi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nagaraj, Ashwini S., Jennifer R. Devlin, Annabrita Hemmes, et al.. (2019). Receptor Tyrosine Kinase Signaling Networks Define Sensitivity to ERBB Inhibition and Stratify Kras -Mutant Lung Cancers. Molecular Cancer Therapeutics. 18(10). 1863–1874. 5 indexed citations
2.
Vesterinen, Tiina, Kaisa Salmenkivi, Harri Mustonen, et al.. (2019). Performance of Finnish biobanks in nationwide pulmonary carcinoid tumour research. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 476(2). 273–283. 3 indexed citations
3.
Närhi, Katja Maria, Ashwini S. Nagaraj, Elina Parri, et al.. (2018). Spatial aspects of oncogenic signalling determine the response to combination therapy in slice explants from Kras‐driven lung tumours. The Journal of Pathology. 245(1). 101–113. 19 indexed citations
4.
Vesterinen, Tiina, Kaisa Salmenkivi, Harri Mustonen, et al.. (2018). Clinicopathological indicators of survival among patients with pulmonary carcinoid tumor. Acta Oncologica. 57(8). 1109–1116. 22 indexed citations
5.
Salmenkivi, Kaisa & Aija Knuuttila. (2014). [Diagnostics of non-small cell lung carcinoma].. PubMed. 130(7). 701–4. 1 indexed citations
6.
Nymark, Penny, Mervi Aavikko, Salla Ruosaari, et al.. (2012). Accumulation of genomic alterations in 2p16, 9q33.1 and 19p13 in lung tumours of asbestos‐exposed patients. Molecular Oncology. 7(1). 29–40. 15 indexed citations
7.
Leppäranta, Outi, Carla Sens, Kaisa Salmenkivi, et al.. (2012). Regulation of TGF-β storage and activation in the human idiopathic pulmonary fibrosis lung. Cell and Tissue Research. 348(3). 491–503. 58 indexed citations
8.
Pulkkinen, Ville, Kaisa Salmenkivi, Vuokko L. Kinnula, et al.. (2011). A novel screening method detects herpesviral DNA in the idiopathic pulmonary fibrosis lung. Annals of Medicine. 44(2). 178–186. 27 indexed citations
9.
Heinonen, Mira, Annabrita Hemmes, Kaisa Salmenkivi, et al.. (2011). Role of RNA binding protein HuR in ductal carcinoma in situ of the breast. The Journal of Pathology. 224(4). 529–539. 39 indexed citations
10.
Kettunen, Eeva, Mervi Aavikko, Penny Nymark, et al.. (2009). DNA copy number loss and allelic imbalance at 2p16 in lung cancer associated with asbestos exposure. British Journal of Cancer. 100(8). 1336–1342. 22 indexed citations
11.
Ilonen, Ilkka, Jari Räsänen, Eero Sihvo, et al.. (2009). Oxidative stress in non-small cell lung cancer: Role of nicotinamide adenine dinucleotide phosphate oxidase and glutathione. Acta Oncologica. 48(7). 1054–1061. 20 indexed citations
12.
Nymark, Penny, Eeva Kettunen, Mervi Aavikko, et al.. (2009). Molecular Alterations at 9q33.1 and Polyploidy in Asbestos-Related Lung Cancer. Clinical Cancer Research. 15(2). 468–475. 12 indexed citations
13.
Boguslawski, Kristina von, et al.. (2009). The expression of p53, bcl-2, bax, fas and fasL in the primary tumour and lymph node metastases of breast cancer. Acta Oncologica. 48(8). 1137–1143. 19 indexed citations
14.
Guled, Mohamed, Leo Lahti, Pamela Lindholm, et al.. (2009). CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant mesothelioma—A miRNA microarray analysis. Genes Chromosomes and Cancer. 48(7). 615–623. 216 indexed citations
15.
Myllärniemi, Marjukka, Pamela Lindholm, Corrine R. Kliment, et al.. (2007). Gremlin-mediated Decrease in Bone Morphogenetic Protein Signaling Promotes Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. 177(3). 321–329. 152 indexed citations
16.
Salmenkivi, Kaisa, Lea Pylkkänen, Markku Sainio, et al.. (2006). Frequent loss of heterozygosity at 6q in pheochromocytoma. Human Pathology. 37(6). 749–754. 21 indexed citations
17.
Wikman, Harriet, Kaisa Salmenkivi, Eeva Kuosma, et al.. (2006). Increased expression of high mobility group A proteins in lung cancer. The Journal of Pathology. 209(2). 206–212. 156 indexed citations
18.
Wikman, Harriet, Virinder Kaur Sarhadi, Eeva Kettunen, et al.. (2004). Caveolins as Tumor Markers in Lung Cancer Detected by Combined Use of cDNA and Tissue Microarrays. American Journal Of Pathology. 203. 584–593. 2 indexed citations
19.
Salmenkivi, Kaisa, Päivi Heikkilä, Caj Haglund, Johanna Louhimo, & Johanna Arola. (2003). Lack of histologically suspicious features, proliferative activity, and p53 expression suggests benign diagnosis in phaeochromocytomas. Histopathology. 43(1). 62–71. 21 indexed citations
20.
Salmenkivi, Kaisa, Caj Haglund, Ari Ristimäki, Johanna Arola, & Päivi Heikkilä. (2001). Increased Expression of Cyclooxygenase-2 in Malignant Pheochromocytomas. The Journal of Clinical Endocrinology & Metabolism. 86(11). 5615–5619. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jean-Michel Vignaud Breakdown of academic impact, for papers by Aurélie Cazes Breakdown of academic impact, for papers by Stephen M. Bonsib Breakdown of academic impact, for papers by Chin‐Chen Pan Breakdown of academic impact, for papers by Shogo Katsuda Breakdown of academic impact, for papers by Maria A. Pantaleo Breakdown of academic impact, for papers by Robert Stöhr Breakdown of academic impact, for papers by Claudio Di Cristofano Breakdown of academic impact, for papers by Seiichi Tamai Breakdown of academic impact, for papers by Yoshiaki Inayama
Rankless by CCL
2026